Showing results (501-510 of 537) with videos related to

Sort By:
Pageof 54
Tissue Antigens|April 1, 1994
HLA-B15: a widespread and diverse family of HLA-B allelesW H Hildebrand, J D Domena, S Y Shen, et al.
Blood Cancer Journal|July 26, 2012
Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain productionF L Khanim, B A M E Merrick, H V Giles, et al.
Cancer Research|May 7, 2015
Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty AcidsAndrew D Southam, Farhat L Khanim, Rachel E Hayden, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2009
The evolutionary history of the extinct ratite moa and New Zealand Neogene paleogeographyM Bunce, T H Worthy, M J Phillips, et al.
Cancer Research|January 25, 2003
The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugsJulian C Desmond, Joanne C Mountford, Mark T Drayson, et al.
Chemistry & Biology|December 23, 2008
Supramolecular iron cylinder with unprecedented DNA binding is a potent cytostatic and apoptotic agent without exhibiting genotoxicityAnna C G Hotze, Nikolas J Hodges, Rachel E Hayden, et al.
Mutation Research|January 24, 2009
The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: implications for leukemogenesisJane Birtwistle, Rachel E Hayden, Farhat L Khanim, et al.
Tissue Antigens|July 31, 2007
Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosisP Spagnolo, H Sato, J C Grutters, et al.
Bioorganic & Medicinal Chemistry Letters|January 6, 2012
Design and synthesis of potent carboxylic acid DGAT1 inhibitors with high cell permeabilityUstav Bali, Oscar Barba, Graham Dawson, et al.
Rheumatology (Oxford, England)|April 19, 2002
Immune responses to native beta(2)-glycoprotein I in patients with systemic lupus erythematosus and the antiphospholipid syndromeM L Davies, S P Young, K Welsh, et al.
Pageof 54